Skip to main content

Table 7 Subgroup analysis of primary outcome

From: Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan

 

Ceftriaxone + standard care (n = …)

Standard care (n = …)

P

OR 95% CI

Favorable outcome (mRS* 0 to 2) - % n/N

    

- Ischemic stroke

    

- Hemorrhagic stroke

    

- Transient ischemic attack (TIA)

    

- Other

    

Favorable outcome (mRS 0 to 2) - % n/N

    

- NIHSS** 1 to 9

    

- NIHSS 10 to 30

    

Favorable outcome (mRS 0 to 2) - % n/N

    

- time to treatment 0 to 6 h

    

- time to treatment 6 to 12 h

    

- time to treatment 12 to 24 h

    
  1. *mRS, denotes modified Rankin Scale.
  2. **NIHSS denotes National Institutes of Health Stroke Scale.
Back to article page

Trials

ISSN: 1745-6215